Teijin Pharma Releases SAS Testing Device.
With the device, a suspected SAS patient can record his/her respiratory conditions while sleeping, and medical institutions can download those data to PCs for analysis using dedicated software. The price is set at 775,000 yen.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Aug 22, 2006|
|Previous Article:||PAYGENT Launches Escrow Service for Mobile Auction Websites.|
|Next Article:||Tohoku University Unveils the Effect of Light Environment on the Brains of Premature Infants.|